Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,045 | 33,454 | 36,953 | 40,845 | 44,355 |
| Other current assets | 0 | 684 | 674 | 0 | 0 |
| TOTAL | $31,328 | $34,138 | $37,627 | $41,107 | $44,739 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 251 | 280 | 321 |
| Intangibles | 34 | 35 | 36 | 37 | 37 |
| TOTAL | $34 | $35 | $287 | $317 | $358 |
| Total Assets | $31,362 | $34,173 | $37,914 | $41,424 | $45,097 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 467 | 115 | 335 | 421 | 189 |
| Accrued Expenses | 2,303 | 2,079 | 1,077 | 1,387 | 2,315 |
| TOTAL | $2,770 | $2,210 | $1,420 | $1,808 | $2,520 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 632 | 968 | 41 | 59 | 183 |
| TOTAL | $632 | $968 | $41 | $59 | $183 |
| Total Liabilities | $3,402 | $3,178 | $1,461 | $1,867 | $2,703 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,136 | 2,136 | 2,136 | N/A | 2,070 |
| Common Shares | 641 | 641 | 641 | 622 | 622 |
| Retained earnings | -260,474 | -257,379 | -251,511 | -248,296 | -245,064 |
| Other shareholders' equity | 0 | 0 | 0 | 19 | 19 |
| TOTAL | $27,960 | $30,995 | $36,453 | $39,557 | $42,394 |
| Total Liabilities And Equity | $31,362 | $34,173 | $37,914 | $41,424 | $45,097 |